No abstract available
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Anticholesteremic Agents / therapeutic use*
-
Azetidines / therapeutic use*
-
Biomarkers / blood
-
Cholesterol, LDL / blood
-
Cholesterol, LDL / drug effects*
-
Dyslipidemias / blood
-
Dyslipidemias / diagnosis
-
Dyslipidemias / drug therapy*
-
Glucuronides / therapeutic use*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hyperlipoproteinemia Type II / drug therapy
-
Meta-Analysis as Topic
-
Proprotein Convertase 9
-
Proprotein Convertases / antagonists & inhibitors*
-
Randomized Controlled Trials as Topic
-
Serine Endopeptidases
-
Treatment Outcome
Substances
-
Anticholesteremic Agents
-
Azetidines
-
Biomarkers
-
Cholesterol, LDL
-
Glucuronides
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
ezetimibe glucuronide
-
PCSK9 protein, human
-
Proprotein Convertase 9
-
Proprotein Convertases
-
Serine Endopeptidases